Baiyun Mountain confirms its subsidiary's production of radiation-resistant drugs rising more than 7% today

NetEase Finance March 17 News by Japan Earthquake Impact, the recent concept of radiation protection company by investors chasing. Baiyun Mountain A announced today, the holding subsidiary of Guangzhou Buishan Pharmaceutical production of anti-radiation drug potassium iodide tablets, but because the drug production by strict examination and approval control, its sales revenue contributed very little.　　The company is also expected to profit about 66.38 million to 99.56 million yuan in the first quarter of this year, an increase of 0% to 50%. According to the announcement, the Baiyun Mountain a holds 84.48% shares of Guanghua Pharmaceutical, the company is a nuclear emergency special potassium iodide tablets, one of the main production enterprises, but at present there are other domestic and international production of similar products enterprises.　　2010, Guanghua Pharmaceutical Nuclear emergency special potassium iodide tablets sales revenue of 251,800 yuan, accounting for the company 316 million yuan operating income of 0.08%. Be stimulated by this message. Baiyun Mountain a outstanding performance today, opened up more than 7%, rapid inflow of funds, volume continued to enlarge. Responsible Editor: NF058